Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Fundación Española de Hematología y Hemoterapía clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Spain and Portugal registers with Fundación Española de Hematología y Hemoterapía as lead sponsor. Synced 16 Nov 2026
5Current trials
4Recruiting now
0Drugs in these trials
2Trial registers
At a glance

Fundación Española de Hematología y Hemoterapía is the lead sponsor of 5 current clinical trials in our Spain and Portugal registers. 4 are recruiting patients now. All registered phases are Observational. The most-studied condition is Acquired Thrombotic Thrombocytopenic Purpura.

ClinicalTrials.gov trials by status

  • Recruiting480%
  • Active, closed120%

Trials by phase

  • Observational5100%
01

Clinical trials sponsored by Fundación Española de Hematología y Hemoterapía

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
NCT05992532 · ClinicalTrials.gov ↗ · Gaucher Disease, Acid SphingoMyelinase Deficiency
Observational Recruiting 2023-05 Spain
Spanish Registry of Patients With IgM Monoclonal Gammopathies
NCT05093153 · ClinicalTrials.gov ↗ · Waldenstrom Macroglobulinemia
Observational Recruiting 2021-10 Spain
Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry
NCT05914441 · ClinicalTrials.gov ↗ · Purpura, Thrombocytopenic
Observational Recruiting 2024-03 Spain
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
NCT06919341 · ClinicalTrials.gov ↗ · ITP - Immune Thrombocytopenia, Primary Immune Thrombocytopenia (ITP)
Observational Recruiting 2024-09 Spain
Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura
NCT05046717 · Acquired Thrombotic Thrombocytopenic Purpura
Observational Active, closed 2022-10 Spain, Portugal

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Fundación Española de Hematología y Hemoterapía trials

7 conditions
Acquired Thrombotic Thrombocytopenic Purpura1Gaucher Disease1Acid SphingoMyelinase Deficiency1Waldenstrom Macroglobulinemia1Purpura, Thrombocytopenic1ITP - Immune Thrombocytopenia1Primary Immune Thrombocytopenia (ITP)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Spain54
Clinical trials in Portugal10

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Acquired Thrombotic Thrombocytopenic Purpura

SponsorTrials
University of Cologne1

Sponsors with the most current trials registered for this condition.

05

Questions about Fundación Española de Hematología y Hemoterapía trials

How many clinical trials does Fundación Española de Hematología y Hemoterapía sponsor?

Fundación Española de Hematología y Hemoterapía is the lead sponsor of 5 current trials on ClinicalTrials.gov in our Spain and Portugal registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are Fundación Española de Hematología y Hemoterapía trials recruiting?

Yes. 4 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.